Ryvyl Inc

RVYL A | $1.44 -12.53% 320K

(0.0% 1d) (-56.7% 1m) (175.1% 1y) (0.0% 2d) (26.0% 3d) (28.9% 7d) (2540.71% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 8,669,519
https://greenboxpos.com
Sec Filling | Patents | 18 employees

GreenBox POS is an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions. The Company's applications enable an end-to-end suite of turnkey financial products, helping to reduce fraud and improve the efficiency of handling large-scale commercial processing volumes for its merchant clients globally.

security education

add to watch list Paper trade email alert is off

C&F Financial Corporation

CFFI A | $36.7 -2.29% 6.6K

Finance

(0.0% 1d) (-22.6% 1m) (-29.6% 1y) (0.0% 2d) (-2.9% 3d) (1.6% 7d) (-19.31% volume)
Earnings Calendar:
Market Cap: $ 123,807,560
http://www.cffc.com
Sec Filling | Patents | 643 employees

(US) C&F Financial Corp. is a bank holding company, which engages in the provision of banking services to individuals and businesses. It operates its business through the following segments: Retail Banking; Mortgage Banking and Consumer Finance. The Retail Banking segment provides checking and savings deposit accounts; and business, real estate, development, mortgage, home equity, and instalment loans. The Mortgage Banking segment offers ancillary mortgage loan origination services for loan settlement and residential appraisals. The Consumer Finance segment comprises of automobile financing through lending programs that are designed to serve customers in the non-prime market who have limited access to traditional automobile financing. The company was founded on March 8, 1994 and is headquartered in West Point, VA.

automobile

add to watch list Paper trade email alert is off

Amarin Corporation plc

AMRN | News | $0.8685 -1.68% 290K

Health Technology

(0.0% 1d) (3.7% 1m) (-31.6% 1y) (0.0% 2d) (0.6% 3d) (-0.6% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 85,809,521
http://amarincorp.com
Sec Filling | Patents | 965 employees

(IE) Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

cardiovascular marine vascepa

add to watch list Paper trade email alert is off

Amylyx Pharmaceuticals, Inc.

AMLX A | $1.895 -2.82% 610K

(0.0% 1d) (-28.0% 1m) (-93.4% 1y) (0.0% 2d) (-1.5% 3d) (-1.5% 7d) (-5.41% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 128,447,153
https://www.amylyx.com
Sec Filling | Patents | 2021 employees

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

taurursodiol als sclerosis sodium phenylbutyrate neurodegenerative

add to watch list Paper trade email alert is off

BNP PARIBAS

BNPQY | News | $36.46 91K

Finance and Insurance

(0.0% 1d) (7.3% 1m) (16.6% 1y) (0.0% 2d) (2.5% 3d) (4.6% 7d) (-6.43% volume)
Earnings Calendar:
Market Cap: $ 83,674,052,664
https://group.bnpparibas/
Sec Filling | Patents | n/a employees

(United Kingdom)

add to watch list Paper trade email alert is off

NOVARTIS AG

NVSEF | News | $96.0 52K

Health Technology

(0.0% 1d) (0.3% 1m) (10.3% 1y) (0.0% 2d) (0.9% 3d) (6.4% 7d) (10458.54% volume)
Earnings Calendar:
Market Cap: $ 213,036,438,720
http://www.novartis.com
Sec Filling | Patents | n/a employees

(CH) Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

add to watch list Paper trade email alert is off

BNP PARIBAS

BNPQF | News | $70.45 1.8K

Finance

(0.0% 1d) (3.3% 1m) (10.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (341.44% volume)
Earnings Calendar:
Market Cap: $ 80,839,783,464
http://www.bnpparibas.com
Sec Filling | Patents | n/a employees

(FR) BNP Paribas SA engages in the provision of banking and financial services. The company operates through the following business: Retail Banking and Services, and Corporate Institutional Banking. The Retail Banking and Services business includes the retail banking networks and specialized financial services in France and around the world. The Corporate Institutional Banking business is a provider of financial solutions to corporate and institutional clients. It helps all its individuals, community associations, entrepreneurs, SMEs, corporate and institutional clients to realize their projects through solutions spanning financing, investment, savings and protection insurance. The company was founded in 1822 and is headquartered in Paris, France.

add to watch list Paper trade email alert is off